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Chlamydia trachomatis is the etiological agent of trachoma, the leading infectious cause of blindness worldwide. We report here
the first complete and annotated genome of a C. trachomatis trachoma-causing serovar C strain (strain TW-3). The chromosome
and plasmid are 1,043,554 bp and 7,501 bp in length, respectively.
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The obligate intracellular bacterium Chlamydia trachomatis isthe major cause of bacterial sexually transmitted infections
worldwide and is also responsible for trachoma, the leading infec-
tious cause of blindness. Trachoma results from a conjunctival
chronic inflammatory state leading to the formation of irrevers-
ible corneal opacities and blindness (1, 2). It is one of 17 neglected
tropical diseases and is targeted for elimination by 2020 by the
World Health Organization (WHO) through the implementation
of the SAFE strategy: lid surgery (S), antibiotics to treat the infec-
tion (A), facial cleanliness (F), and environmental changes (E) (3).
Trachoma affects about 2.2 million people and it is endemic in
50 countries, predominantly in sub-Saharan Africa, the Middle
East, and Asia (2). This epidemiological pattern is essentially as-
sociated withC. trachomatis ocular serovars A and B (4) (from the
existent 15 major serovars), whereas serovar C seems relatively
common in indigenous Australian communities (5, 6). Of note,
serovar C has been also associated with Chlamydia-related arthri-
tis (7). There are already five and two annotated genomes from
serovars A and B (8–10), respectively. We report here the first
complete and annotated sequence of a trachoma-causing C. tra-
chomatis serovar C strain, TW-3.
The C/TW-3 strain was isolated in Taiwan in 1959 from the
human conjunctiva (11). We obtained this strain from the Amer-
ican Type Culture Collection (ATCCVR-1477) and propagated it
in HeLa229 cell monolayers before proceeding with bacterial pu-
rification using discontinuous urographin density gradients (12).
The whole-genome sequence was determined by using a paired-
end strategy (2 250 bp) with the platform Illumina MiSeq. The
reads were mapped to C. trachomatis chromosome and plasmid
sequences (8–10) using both Bowtie 2 (version 2.1.0 [http:
//bowtie-bio.sourceforge.net/bowtie2/index.shtml]) (13) and the
Burrows-Wheeler Aligner (BWA) software (version 0.7.5a [http:
//bio-bwa.sourceforge.net/]) (14). Globally, 5,233,958 reads (with
a mean quality score 30 for 95% of the read bases) were
mapped, which yielded a mean coverage of 1,117-fold and 6,717-
fold for the chromosome and plasmid, respectively. Single-
nucleotide polymorphisms (SNPs) and indels were identified us-
ing SAMtools, followed by variant calling using BCFtools (http:
//samtools.sourceforge.net/) (15), and were carefully inspected
through the Integrative Genomics Viewer (version 2.3.12 [http:
//www.broadinstitute.org/igv/]) (16). Both the typing gene
(ompA) and problematic regions (e.g., tarP) were confirmed by
PCR, followed by Sanger sequencing. The sequencewas annotated
by the NCBI Prokaryotic Genomes Annotation Pipeline 2.3.
The genome sequence of C/TW-3 revealed a chromosome of
1,043,554 bp in length, with a GC content of 41.30% and 922
predicted coding sequences (CDSs). Plasmid analysis revealed the
existence of about six copies per chromosome (based on the ratio
of mean coverage for plasmid/chromosome), which fits with pre-
vious data (17), and the plasmid was found to be 7,501 bp in
length, comprising eight CDSs (GC content of 36.25%).
The availability of a complete and annotated genome sequence
of an additional trachoma-causing serovar may contribute to the
elucidation of the genetic basis underlying the pathogenic differ-
ences between C. trachomatis ocular strains (7, 18, 19).
Nucleotide sequence accession numbers. The complete ge-
nome sequence of C. trachomatis serovar C (strain TW-3) has
been assigned GenBank accession no. CP006945 (chromosome)
and CP006946 (plasmid).
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